Safe prescription of systemic antineoplastic treatment in oncology: integrative literature review

Safe prescription of systemic antineoplastic treatment in oncology: integrative literature review

The objective of this study was to identify the available evidence on the parameters that should be considered to improve the quality and safety of the prescription of systemic antineoplastic treatment. This is an integrative review carried out in the EMBASE, LILACS, and PubMed databases, from 2015...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fabiola Vasconcelos Alves, Renata Cristina de Campos Pereira Silveira, Flavia Oliveira de Almeida Marques da Cruz, Elaine Barros Ferreira, Paula Elaine Diniz dos Reis
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações Ltda. 2022-10-01
Series:	Brazilian Journal of Oncology
Subjects:	antineoplastic agents immunotherapy drug-related side effects and adverse reactions patient safety
Online Access:	https://www.brazilianjournalofoncology.com.br/details/187/en-US/safe-prescription-of-systemic-antineoplastic-treatment-in-oncology--integrative-literature-review
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Educational technology for patient participation in the safe administration of antineoplastic chemotherapy: methodological study
by: Elaine Cristina Salzedas Muniz, et al.
Published: (2025-08-01)

Real world pharmacovigilance study of antineoplastic drug related vitiligo risks
by: Yixuan Yang, et al.
Published: (2025-07-01)

Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients
by: María José Otero, et al.
Published: (2018-11-01)

Evaluation of the Impact of Implementing Electronic Prescription in an Oncology Referral Hospital in Recife, Brazil
by: Diana Carla Gouveia Falcão, et al.
Published: (2025-01-01)

Disproportionality analysis of interstitial lung disease associated with novel antineoplastic agents during breast cancer treatment: a pharmacovigilance studyResearch in context
by: Zijun Zhu, et al.
Published: (2025-04-01)

Exploring the antineoplastic potential of α-mangostin in breast cancer
by: Daniela Amador-Martínez, et al.
Published: (2025-07-01)

Recent development of micro-nano carriers for oral antineoplastic drug delivery
by: Hongzheng Li, et al.
Published: (2025-02-01)

Chemotherapy: some potential risks under antineoplastic drugs handling
by: L. G. Solenova, et al.
Published: (2017-10-01)

Health literacy and therapeutic adherence of patients undergoing oral antineoplastic chemotherapy: a correlational study
by: Yasmin Araujo Braz, et al.
Published: (2025-08-01)

Implementation of an Improvement Cycle in the Compounding of Antineoplastic Therapy in a University Hospital
by: Luciana Moreira Dantas Barreto, et al.
Published: (2025-04-01)

Omission of dexamethasone in prophylaxis for highly emetogenic chemotherapy in patients with breast cancer
by: Camilla Vieira de Rebouças, et al.
Published: (2025-05-01)

Impact of Chemotherapy Alone and in Combination with Immunotherapy on Oral Microbiota in Cancer Patients—A Pilot Study
by: Adriana Padure, et al.
Published: (2025-07-01)

Safety of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2024-04-01)

Assessment of potential drug–drug interactions in an oncology unit of a tertiary care teaching hospital
by: Ramya Kuzhikattu Vayalil, et al.
Published: (2018-01-01)

Imatinib-induced interstitial pneumonitis – a literature review and case report
by: Olga Hilda Orasan, et al.
Published: (2020-04-01)

Effects of monoclonal antibody daratumumab combined with ixazomib-based treatment regimen on survival of patients with relapsed/refractory multiple myeloma
by: Peng Lang, et al.
Published: (2025-01-01)

Local side effects during sublingual allergen-specific immunotherapy and pathogenetically based methods for their correction (Review)
by: V. Ya. Zakurskaya
Published: (2024-06-01)

Exploring the Antineoplastic Properties of the Lebanese <i>Jania rubens</i> Against Colorectal Cancer
by: Mariam Rifi, et al.
Published: (2025-02-01)

Observational study of drug-drug interactions in oncological inpatients
by: María Sacramento Díaz-Carrasco, et al.
Published: (2018-01-01)

Off-label drug use in pediatric patients: a comparative analysis with nationwide routine prescription data
by: Narin Akıcı, et al.
Published: (2020-12-01)

The Benthic Dinoflagellate <i>Coolia malayensis</i> (Dinophyceae) Produces an Array of Compounds with Antineoplastic Activity in Cells of Tumor Origin
by: Itzel B. Morales-Montesinos, et al.
Published: (2025-03-01)

A systematic review of prescription errors in paediatric care
by: GD Hannibal, et al.
Published: (2025-07-01)

Treatment outcomes for adult patients with localized osteosarcoma treated with chemotherapy without methotrexate at a public hospital in Brazil
by: Marilia Polo Minguete-e-Silva, et al.
Published: (2021-10-01)

Features of high-dose intravenous immunotherapy administration in patients with reduced IgA level in neurological practice: literature review and description of a clinical case
by: A. S. Rizvanova, et al.
Published: (2018-10-01)

BMI Association With Treatment Outcomes in Head and Neck Cancer Patients Receiving Immunotherapy: A Comprehensive Review and Meta‐Analysis
by: Sakditad Saowapa, et al.
Published: (2025-02-01)

Risk of autoimmunity, cancer seeding, and adverse events in human trials of whole-tissue autologous therapeutic vaccines
by: Garrett Gianneschi, et al.
Published: (2025-03-01)

Antitumour activity of 1,1-bis-(pyrimidine-2,4-diono-1-il)-2-bromo-2-chloroethylenes substituted molecular complexes and bacterial lectin
by: E. V. Welchinska
Published: (2015-04-01)

State of knowledge of healthcare staff on the risks associated with the handling of cytotoxic drugs: preliminary study carried out at the regional oncology center and the hematology department of the regional hospital of Beni Mellal (Morocco)
by: Hasna Elmortaji, et al.
Published: (2025-06-01)

The gut microbiota during tamoxifen therapy in patients with breast cancer
by: Lars E. Hillege, et al.
Published: (2025-03-01)

Neurologic adverse events of cancer immunotherapy
by: Marcelo Houat de Brito
Published: (2022-08-01)

Gastric Cancer: Molecular Characterization, Therapeutic Innovations, and Perspectives
by: Emily Tonin da Costa, et al.
Published: (2024-01-01)

Synergistic Effect of Angelica gigas and Saccharin on Antiproliferative Activity in Ovcar-3 Cells
by: Sang Yong PARK, et al.
Published: (2025-06-01)

The cancer registry as an ally in monitoring treatment effectiveness
by: F.A. Costa, et al.
Published: (2019-01-01)

WHAT TO DO WITH A VARIETY OF TERMS THAT REFLECT THE HARM OF DRUGS?
by: Yu. V. Muravyev, et al.
Published: (2017-04-01)

Preoperatory treatment of adenocarcinoma of the rectum: historical analysis and correlation between tumor regression grade and the outcomes
by: Jeziel Basso, et al.
Published: (2022-10-01)

Cancer Symptom Clusters in Children and Adolescents with Cancer Undergoing Chemotherapy: A Systematic Review
by: Luís Carlos Lopes-Júnior, et al.
Published: (2025-05-01)

Study of the use possibility of the chemical-biological adduct of the 1,1-bis-[5-bromopyrimidine-2’,4’-diono-1’-il]-2-bromo-2’-chloroethylene and bacterial lectin for the treatment of the Pliss’ lymphosarcoma
by: O. V. Welchinska
Published: (2015-04-01)

The role of circRNA in breast cancer drug resistance
by: Shaofeng Yang, et al.
Published: (2024-12-01)

Pet cancer cases and patterns of treatment at a Spanish veterinary teaching hospital: a retrospective study from 2015 to 2024
by: Beatriz Romero, et al.
Published: (2025-07-01)

Norfloxacin Derivative with Carbazole at C-7 FQB-1 Induces Cytotoxic, Antiproliferative, and Antitumor Effects in an Experimental Lung Carcinoma Model
by: Alondra Bocanegra-Zapata, et al.
Published: (2025-04-01)